Inspire Medical Systems, Inc.(INSP)Earnings, Financials & Key Ratios

INSP•NYSE

$45.70

$1.32B mkt cap·9.3× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryRespiratory and sleep therapy devices

AboutInspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.Show more

Revenue$912M+13.6%
EBITDA$65M+52.3%
Net Income$145M+171.8%
EPS (Diluted)4.89+179.4%
Gross Margin85.39%+0.8%
EBITDA Margin7.12%+34.0%
Operating Margin5.59%+24.3%
Net Margin15.95%+139.2%
ROE19.77%+133.2%
ROIC5.97%+8.5%
Debt/Equity0.04-10.7%
Interest Coverage371.93-86.0%

Technical→

INSP Key Insights

Inspire Medical Systems, Inc. (INSP) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 7/9
✓Strong 5Y sales CAGR of 51.2%
✓Share count reduced 2.6% through buybacks
✓Efficient asset utilization: 1.0x turnover

✗Weaknesses

✗Weak momentum: RS Rating 14 (bottom 14%)
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

INSP Price & Volume

Inspire Medical Systems, Inc. (INSP) stock price & volume — 10-year historical chart

Loading chart...

INSP Growth Metrics

Inspire Medical Systems, Inc. (INSP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years51.21%

3 Years30.77%

TTM8.94%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM97.18%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM107.04%

Return on Capital

10 Years-51.99%

5 Years-4.65%

3 Years1.61%

Last Year6.66%

INSP Recent Earnings

Inspire Medical Systems, Inc. (INSP) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 12/12 qtrs (100%)●Beat Revenue 8/12 qtrs (67%)

Q2 2026Latest

May 4, 2026

EPS

$0.10

Est $0.28

+136.3%

Revenue

$205M

Est $200M

+2.3%

Q1 2026

Feb 11, 2026

EPS

$1.65

Est $0.69

+139.1%

Revenue

$269M

Est $266M

+1.3%

Q4 2025

Nov 3, 2025

EPS

$0.38

Est $0.15

+353.3%

Revenue

$225M

Est $262M

-14.4%

Q3 2025

Aug 4, 2025

EPS

$0.45

Est $0.22

+104.5%

Revenue

$217M

Est $214M

+1.2%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 4, 2026	$0.10vs $0.28+136.3%	$205Mvs $200M+2.3%
Q1 2026	Feb 11, 2026	$1.65vs $0.69+139.1%	$269Mvs $266M+1.3%
Q4 2025	Nov 3, 2025	$0.38vs $0.15+353.3%	$225Mvs $262M-14.4%
Q3 2025	Aug 4, 2025	$0.45vs $0.22+104.5%	$217Mvs $214M+1.2%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
NVCRNovoCure LimitedDirect Competitor	1.88B	16.50	-13.52	8.28%	-25.66%	-50.82%	0.85
TNDMTandem Diabetes Care, Inc.Direct Competitor	1.24B	18.03	-5.93	7.93%	-20.17%	-141.98%	2.86
IRTCiRhythm Technologies, Inc.Direct Competitor	3.87B	117.70	-84.68	26.24%	-3.53%	-20.6%	4.79
MDTMedtronic plcProduct Competitor	99.48B	77.60	21.50	3.62%	13%	9.45%	0.59
ABTAbbott LaboratoriesProduct Competitor	149.97B	86.25	11.29	4.59%	31.88%	27.26%	0.32
BSXBoston Scientific CorporationProduct Competitor	83.23B	56.00	28.87	19.87%	14.4%	12.4%	0.51
LVSLas Vegas Sands Corp.Product Competitor	35.32B	53.22	22.65	15.22%	13.41%	95.8%	8.34
RGENRepligen CorporationSupply Chain	7.09B	125.76	146.23	16.36%	6.73%	2.46%	0.33

Compare INSP vs Peers

Inspire Medical Systems, Inc. (INSP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NVCR

Most directly comparable listed peer for INSP.

Scale Benchmark

vs ABT

Larger-name benchmark to compare INSP against a more recognizable public peer.

Peer Set

Compare Top 5

vs NVCR, TNDM, IRTC, MDT

INSP Income Statement

Inspire Medical Systems, Inc. (INSP) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	28.57M	50.59M	82.05M	115.38M	233.39M	407.86M	624.8M	802.8M	911.98M	915.25M
Revenue Growth %	73.9%	77.1%	62.18%	40.62%	102.28%	74.75%	53.19%	28.49%	13.6%	8.94%
Cost of Goods Sold	6.02M	10.06M	13.64M	17.62M	33.28M	66.11M	96.58M	122.99M	133.22M	130.19M
COGS % of Revenue	21.07%	19.88%	16.63%	15.27%	14.26%	16.21%	15.46%	15.32%	14.61%	-
Gross Profit	22.55M▲ 0%	40.54M▲ 79.8%	68.41M▲ 68.8%	97.76M▲ 42.9%	200.12M▲ 104.7%	341.74M▲ 70.8%	528.22M▲ 54.6%	679.82M▲ 28.7%	778.76M▲ 14.6%	785.06M▲ 0%
Gross Margin %	78.93%	80.12%	83.37%	84.73%	85.74%	83.79%	84.54%	84.68%	85.39%	85.78%
Gross Profit Growth %	80.08%	79.77%	68.75%	42.91%	104.7%	70.77%	54.57%	28.7%	14.55%	-
Operating Expenses	38.55M	60.91M	103.3M	153.97M	239.97M	389.33M	568.49M	643.74M	727.8M	733.74M
OpEx % of Revenue	134.95%	120.4%	125.9%	133.44%	102.82%	95.46%	90.99%	80.19%	79.8%	-
Selling, General & Admin	32.36M	53.53M	90.47M	127.87M	202.62M	320.69M	451.96M	529.61M	624.64M	632.55M
SG&A % of Revenue	113.27%	105.8%	110.26%	110.83%	86.81%	78.63%	72.34%	65.97%	68.49%	-
Research & Development	6.19M	7.39M	12.84M	26.09M	37.35M	68.64M	116.54M	114.13M	103.17M	101.19M
R&D % of Revenue	21.68%	14.6%	15.65%	22.61%	16%	16.83%	18.65%	14.22%	11.31%	-
Other Operating Expenses	42K	-16K	0	0	0	0	0	0	0	0
Operating Income	-16M▲ 0%	-20.38M▼ 27.3%	-34.9M▼ 71.2%	-56.21M▼ 61.1%	-39.85M▲ 29.1%	-47.59M▼ 19.4%	-40.27M▲ 15.4%	36.08M▲ 189.6%	50.95M▲ 41.2%	51.32M▲ 0%
Operating Margin %	-56.02%	-40.28%	-42.53%	-48.72%	-17.07%	-11.67%	-6.45%	4.49%	5.59%	5.61%
Operating Income Growth %	7.25%	-27.34%	-71.25%	-61.07%	29.1%	-19.43%	15.38%	189.6%	41.21%	-
EBITDA	-15.72M	-19.98M	-34.4M	-55.37M	-38.63M	-45.73M	-37.42M	42.63M	64.91M	62.23M
EBITDA Margin %	-55.02%	-39.5%	-41.93%	-47.99%	-16.55%	-11.21%	-5.99%	5.31%	7.12%	6.8%
EBITDA Growth %	8.35%	-27.15%	-72.14%	-60.94%	30.23%	-18.38%	18.17%	213.92%	52.26%	6.25%
D&A (Non-Cash Add-back)	285K	393K	495K	840K	1.22M	1.86M	2.85M	6.55M	13.96M	10.91M
EBIT	-15.76M	-18.52M	-31.08M	-54.97M	-39.84M	-42.59M	-19.91M	58.48M	50.95M	57.34M
Net Interest Income	-1.55M	-1.43M	1.68M	-1.02M	-2M	3.37M	20.56M	23.23M	17.4M	12.33M
Interest Income	203K	1.87M	3.8M	1.09M	125K	5.05M	20.56M	23.25M	17.54M	12.47M
Interest Expense	1.75M	3.3M	2.12M	2.12M	2.13M	1.68M	0	22K	137K	137K
Other Income/Expense	-1.51M	-1.45M	1.69M	-880K	-2.12M	3.32M	20.36M	22.37M	14.74M	12.61M
Pretax Income	-17.51M▲ 0%	-21.83M▼ 24.7%	-33.2M▼ 52.1%	-57.09M▼ 71.9%	-41.97M▲ 26.5%	-44.27M▼ 5.5%	-19.91M▲ 55.0%	58.45M▲ 393.6%	65.7M▲ 12.4%	63.94M▲ 0%
Pretax Margin %	-61.3%	-43.14%	-40.47%	-49.48%	-17.98%	-10.85%	-3.19%	7.28%	7.2%	6.99%
Income Tax	0	0	40K	115K	72K	613K	1.25M	4.94M	-79.72M	-67.2M
Effective Tax Rate %	0%	0%	-0.12%	-0.2%	-0.17%	-1.38%	-6.26%	8.46%	-121.35%	-105.11%
Net Income	-17.51M▲ 0%	-21.83M▼ 24.7%	-33.24M▼ 52.3%	-57.2M▼ 72.1%	-42.04M▲ 26.5%	-44.88M▼ 6.8%	-21.15M▲ 52.9%	53.51M▲ 353.0%	145.42M▲ 171.8%	131.14M▲ 0%
Net Margin %	-61.3%	-43.14%	-40.52%	-49.58%	-18.01%	-11%	-3.39%	6.67%	15.95%	14.33%
Net Income Growth %	5.49%	-24.65%	-52.3%	-72.08%	26.5%	-6.75%	52.87%	352.96%	171.77%	97.18%
Net Income (Continuing)	-17.51M	-21.83M	-33.24M	-57.2M	-42.04M	-44.88M	-21.15M	53.51M	145.42M	131.14M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-1.30▲ 0%	-1.50▼ 15.4%	-1.40▲ 6.7%	-2.19▼ 56.4%	-1.54▲ 29.7%	-1.60▼ 3.9%	-0.72▲ 55.0%	1.75▲ 343.1%	4.89▲ 179.4%	4.57▲ 0%
EPS Growth %	12.75%	-15.38%	6.67%	-56.43%	29.68%	-3.9%	55%	343.06%	179.43%	107.04%
EPS (Basic)	-1.30	-1.50	-1.40	-2.19	-1.54	-1.60	-0.72	1.80	4.95	-
Diluted Shares Outstanding	13.49M	14.58M	23.8M	26.07M	27.26M	28.07M	29.3M	30.54M	29.76M	28.7M
Basic Shares Outstanding	13.49M	14.58M	23.8M	26.07M	27.26M	28.07M	29.3M	29.76M	29.37M	28.7M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

INSP Balance Sheet

Inspire Medical Systems, Inc. (INSP) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	24.1M	199.28M	170.64M	269.87M	268.54M	530.03M	593.74M	630.81M	583.65M	566.82M
Cash & Short-Term Investments	16.14M	188.21M	149.47M	234.36M	214.47M	451.41M	460.38M	445.55M	308.27M	98.93M
Cash Only	8.96M	97.29M	22.86M	190.52M	214.47M	441.59M	185.54M	150.15M	104.81M	98.93M
Short-Term Investments	7.19M	90.92M	126.61M	43.84M	0	9.82M	274.84M	295.4M	203.46M	0
Accounts Receivable	3.86M	6.67M	13.13M	25.06M	34.18M	61.23M	89.88M	93.07M	119.69M	105.09M
Days Sales Outstanding	49.29	48.1	58.41	79.29	53.45	54.79	52.51	42.31	47.9	46.9
Inventory	3.67M	2.67M	5.83M	8.48M	17.23M	11.89M	33.88M	80.12M	145.29M	166.24M
Days Inventory Outstanding	222.59	96.8	156.08	175.61	188.99	65.62	128.07	237.78	398.06	402.98
Other Current Assets	426K	1.73M	0	0	0	5.5M	9.6M	12.07M	10.4M	196.56M
Total Non-Current Assets	994K	802K	10.62M	11.32M	26.55M	34.84M	83.07M	177.58M	323.67M	344.56M
Property, Plant & Equipment	994K	802K	3.96M	11.12M	16.41M	24.13M	62.65M	95.24M	121.4M	123.76M
Fixed Asset Turnover	28.74x	63.08x	20.72x	10.38x	14.23x	16.90x	9.97x	8.43x	7.51x	7.78x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	6.28M	0	9.94M	0	9.14M	71M	96.33M	426.8M
Other Non-Current Assets	0	0	381K	204K	204K	10.71M	11.28M	11.34M	6.09M	44.79M
Total Assets	25.09M▲ 0%	200.08M▲ 697.4%	181.25M▼ 9.4%	281.19M▲ 55.1%	295.08M▲ 4.9%	564.88M▲ 91.4%	676.81M▲ 19.8%	808.38M▲ 19.4%	907.32M▲ 12.2%	911.38M▲ 0%
Asset Turnover	1.14x	0.25x	0.45x	0.41x	0.79x	0.72x	0.92x	0.99x	1.01x	1.06x
Asset Growth %	91.3%	697.42%	-9.41%	55.14%	4.94%	91.43%	19.82%	19.44%	12.24%	49.91%
Total Current Liabilities	7.15M	11.15M	16.86M	20.73M	41.31M	61.19M	78.11M	88.5M	96.06M	89.42M
Accounts Payable	3M	3.43M	4.46M	7.21M	11.66M	26.85M	38.84M	38.69M	36.56M	41.85M
Days Payables Outstanding	181.83	124.46	119.29	149.31	127.94	148.21	146.79	114.82	100.18	133.75
Short-Term Debt	0	0	0	0	9.19M	0	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	555K	1.24M	0	0	0	0	0	0	8.41M	47.57M
Current Ratio	3.37x	17.86x	10.12x	13.02x	6.50x	8.66x	7.60x	7.13x	6.08x	6.08x
Quick Ratio	2.86x	17.63x	9.78x	12.61x	6.08x	8.47x	7.17x	6.22x	4.56x	4.56x
Cash Conversion Cycle	90.05	20.44	95.2	105.59	114.5	-27.8	33.79	165.27	345.79	316.14
Total Non-Current Liabilities	16.62M	24.93M	24.56M	30.72M	24.73M	7.68M	26.19M	30.19M	30.1M	29.62M
Long-Term Debt	16.46M	24.93M	24.52M	24.75M	15.8M	7.54M	0	0	0	29.55M
Capital Lease Obligations	0	0	0	5.89M	8.8M	7.54M	24.85M	30.04M	30M	91.21M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	11.18M
Other Non-Current Liabilities	157K	0	40K	85K	134K	-7.39M	1.35M	148K	104K	-29.61M
Total Liabilities	23.61M	36.08M	41.42M	51.44M	66.04M	68.87M	104.3M	118.69M	126.16M	119.04M
Total Debt	16.46M	24.93M	25.35M	30.63M	34.09M	16.41M	24.85M	31.79M	32.16M	29.55M
Net Debt	7.5M	-72.36M	2.49M	-159.89M	-180.37M	-425.18M	-160.69M	-118.36M	-72.66M	-69.38M
Debt / Equity	11.09x	0.15x	0.18x	0.13x	0.15x	0.03x	0.04x	0.05x	0.04x	0.04x
Debt / EBITDA	-	-	-	-	-	-	-	0.75x	0.50x	0.47x
Net Debt / EBITDA	-	-	-	-	-	-	-	-2.78x	-1.12x	-1.12x
Interest Coverage	-8.99x	-5.61x	-14.67x	-25.97x	-18.72x	-25.40x	-	2657.95x	371.93x	418.58x
Total Equity	1.48M▲ 0%	164M▲ 10951.1%	139.84M▼ 14.7%	229.75M▲ 64.3%	229.05M▼ 0.3%	496.01M▲ 116.6%	572.51M▲ 15.4%	689.7M▲ 20.5%	781.16M▲ 13.3%	792.34M▲ 0%
Equity Growth %	122.46%	10951.15%	-14.73%	64.3%	-0.3%	116.55%	15.42%	20.47%	13.26%	39.8%
Book Value per Share	0.11	11.25	5.87	8.81	8.40	17.67	19.54	22.58	26.25	27.61
Total Shareholders' Equity	1.48M	164M	139.84M	229.75M	229.05M	496.01M	572.51M	689.7M	781.16M	792.34M
Common Stock	13K	23K	24K	27K	27K	29K	30K	30K	29K	29K
Retained Earnings	-125.08M	-146.91M	-180.16M	-237.35M	-279.39M	-324.27M	-345.42M	-291.91M	-146.49M	-157.79M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	-52K	102K	29K	-55K	-86K	800K	536K	464K	-352K
Minority Interest	0	0	0	0	0	0	0	0	0	0

INSP Cash Flow Statement

Inspire Medical Systems, Inc. (INSP) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	-15.79M	-18.69M	-33.38M	-53.05M	-20.12M	11.57M	24.65M	130.25M	116.98M	116.98M
Operating CF Margin %	-55.28%	-36.95%	-40.68%	-45.97%	-8.62%	2.84%	3.95%	16.22%	12.83%	-
Operating CF Growth %	12.02%	-18.38%	-78.54%	-58.93%	62.07%	157.5%	113.1%	428.32%	-10.19%	3839.63%
Net Income	-17.51M	-21.83M	-33.24M	-57.2M	-42.04M	-44.88M	-21.15M	53.51M	145.42M	131.14M
Depreciation & Amortization	285K	393K	1.4M	840K	1.99M	2.9M	2.85M	6.55M	13.96M	16.02M
Stock-Based Compensation	243K	1.22M	0	12.82M	0	0	82.47M	116.01M	0	129.93M
Deferred Taxes	100K	-53K	0	-22K	0	0	0	0	-88.75M	1.01M
Other Non-Cash Items	315K	714K	5.04M	1.4M	26.79M	51.74M	1.27M	-7.51M	133.73M	-84.48M
Working Capital Changes	777K	861K	-6.57M	-10.88M	-6.86M	1.81M	-40.78M	-37.71M	-87.38M	-57.08M
Change in Receivables	-1.77M	-2.84M	-6.48M	-11.84M	-9.24M	-27.02M	-30.22M	-2.6M	-26.23M	-12.21M
Change in Inventory	-315K	1M	-3.17M	-2.65M	-8.75M	5.34M	-22M	-46.23M	-65.17M	-66.51M
Change in Payables	1.82M	439K	1.03M	2.05M	4.78M	14.36M	9.3M	604K	-3.75M	12.9M
Cash from Investing	-7.6M	-83.39M	-43.56M	86.63M	29.14M	-19.6M	-294.82M	-113.12M	21.45M	11.75M
Capital Expenditures	-412K	-250K	-2.74M	-2.46M	-4.67M	-9.1M	-23.63M	-39.12M	-38.5M	-39.82M
CapEx % of Revenue	1.44%	0.49%	3.34%	2.13%	2%	2.23%	3.78%	4.87%	4.22%	-
Acquisitions	0	0	0	-89.08M	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-7.19M	-83.14M	0	89.08M	0	-10.5M	0	0	0	0
Cash from Financing	25.66M	190.38M	2.5M	134.06M	14.95M	235.08M	13.95M	-52.39M	-183.45M	-103.17M
Debt Issued (Net)	458K	8M	0	0	0	-24.5M	0	0	0	0
Equity Issued (Net)	25.2M	182.38M	2.5M	134.06M	14.95M	259.62M	31.11M	-47.23M	-160.41M	-91.73M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	-75M	-175.02M	-100.01M
Other Financing	0	0	0	0	0	-43K	-17.16M	-5.17M	-23.04M	-11.44M
Net Change in Cash	2.27M▲ 0%	88.33M▲ 3791.3%	-74.43M▼ 184.3%	167.66M▲ 325.3%	23.95M▼ 85.7%	227.13M▲ 848.4%	-256.06M▼ 212.7%	-35.39M▲ 86.2%	-45.34M▼ 28.1%	45.05M▲ 0%
Free Cash Flow	-16.2M▲ 0%	-18.94M▼ 16.9%	-35.59M▼ 87.8%	-55.5M▼ 56.0%	-24.79M▲ 55.3%	2.47M▲ 110.0%	1.02M▼ 58.6%	91.12M▲ 8798.7%	78.48M▼ 13.9%	96.71M▲ 0%
FCF Margin %	-56.72%	-37.44%	-43.37%	-48.1%	-10.62%	0.61%	0.16%	11.35%	8.61%	10.57%
FCF Growth %	11.24%	-16.92%	-87.84%	-55.96%	55.34%	109.98%	-58.59%	8798.73%	-13.88%	22.65%
FCF per Share	-1.20	-1.30	-1.49	-2.13	-0.91	0.09	0.03	2.98	2.64	2.64
FCF Conversion (FCF/Net Income)	0.90x	0.86x	1.00x	0.93x	0.48x	-0.26x	-1.17x	2.43x	0.80x	0.74x
Interest Paid	0	0	2.03M	0	1.89M	2.32M	0	22K	0	133K
Taxes Paid	0	0	0	0	0	0	0	0	0	0

INSP Key Ratios

Inspire Medical Systems, Inc. (INSP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	-1179.99%	-26.38%	-21.88%	-30.96%	-18.33%	-12.38%	-3.96%	8.48%	19.77%	17.98%
Return on Invested Capital (ROIC)	-210.81%	-30.38%	-22.37%	-39.73%	-50.43%	-59.74%	-12.52%	5.51%	5.97%	5.97%
Gross Margin	78.93%	80.12%	83.37%	84.73%	85.74%	83.79%	84.54%	84.68%	85.39%	85.78%
Net Margin	-61.3%	-43.14%	-40.52%	-49.58%	-18.01%	-11%	-3.39%	6.67%	15.95%	14.33%
Debt / Equity	11.09x	0.15x	0.18x	0.13x	0.15x	0.03x	0.04x	0.05x	0.04x	0.04x
Interest Coverage	-8.99x	-5.61x	-14.67x	-25.97x	-18.72x	-25.40x	-	2657.95x	371.93x	418.58x
FCF Conversion	0.90x	0.86x	1.00x	0.93x	0.48x	-0.26x	-1.17x	2.43x	0.80x	0.74x
Revenue Growth	73.9%	77.1%	62.18%	40.62%	102.28%	74.75%	53.19%	28.49%	13.6%	8.94%

INSP SEC Filings & Documents

Inspire Medical Systems, Inc. (INSP) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 5, 2026·SEC

Material company update

May 4, 2026·SEC

Material company update

Feb 11, 2026·SEC

10-K Annual Reports

FY 2026

Feb 13, 2026·SEC

FY 2025

Feb 10, 2025·SEC

FY 2024

Feb 9, 2024·SEC

10-Q Quarterly Reports

FY 2026

May 4, 2026·SEC

FY 2025

Nov 3, 2025·SEC

FY 2025

Aug 4, 2025·SEC

INSP Frequently Asked Questions

Inspire Medical Systems, Inc. (INSP) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Inspire Medical Systems, Inc. (INSP) reported $915.2M in revenue for fiscal year 2025. This represents a 5472% increase from $16.4M in 2016.

Inspire Medical Systems, Inc. (INSP) grew revenue by 13.6% over the past year. This is steady growth.

Yes, Inspire Medical Systems, Inc. (INSP) is profitable, generating $131.1M in net income for fiscal year 2025 (15.9% net margin).

Dividend & Returns

Inspire Medical Systems, Inc. (INSP) has a return on equity (ROE) of 19.8%. This is reasonable for most industries.

Inspire Medical Systems, Inc. (INSP) generated $96.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More INSP

Inspire Medical Systems, Inc. (INSP) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Inspire Medical Systems, Inc.(INSP)Earnings, Financials & Key Ratios

INSP Key Insights

✓Strengths

✗Weaknesses

INSP Price & Volume

INSP Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

INSP Recent Earnings

INSP Peer Comparison

Compare INSP vs Peers

vs NVCR

vs ABT

Compare Top 5

INSP Income Statement

INSP Balance Sheet

INSP Cash Flow Statement

INSP Key Ratios

INSP SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

INSP Frequently Asked Questions

Explore More INSP

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation